Facebook
Twitter
YouTube
Instagram
    • español
    • English
  • Contacto
  • español 
    • español
    • English
  • Mi Cuenta
Acerca deAutoresTítulosTemasColeccionesComunidades☰
JavaScript is disabled for your browser. Some features of this site may not work without it.
autores 
    xmlui.general.dspace_homexmlui.ArtifactBrowser.ConfigurableBrowse.trail.metadata.author
  • Inicio
  • autores

Autores

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Ordenar por:

Orden:

Resultados:

Mostrando ítems 1-2 de 2

  • título
  • fecha de publicación
  • fecha de envío
  • ascendente
  • descendente
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • Exosomes Isolated from Ascites of T-Cell Lymphoma-Bearing Mice Expressing Surface CD24 and HSP-90 Induce a Tumor-Specific Immune Response 

      Menay, Florencia; Herschlik, Leticia; De Toro, Julieta; Cocozza, Federico; Tsacalian, Rodrigo Farid; Gravisaco, Marí­a José; Di Sciullo , Maria Paula; Vendrell, Alejandrina; Waldner, Claudia Inés; Mongini, Claudia (2017-03-16)
      Extracellular vesicles (EVs), including endosome-derived nanovesicles (exosomes), are involved in cell–cell communication. Through transfer of their molecular contents, extracellular nanovesicles can alter the function of ...
    • Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma 

      Di Sciullo, Maria Paula; Menay, Florencia; Cocozza, Federico; Gravisaco, María José; Waldner, Claudia Inés; Mongini, Claudia (Elsevier, 2019-06)
      T-cell lymphomas include diverse malignancies. They are rare, some have low survival rates and they lack curative therapies. The aim of this work was to assess whether employing the TLR7 agonist imiquimod and the T-cell ...